Works matching AU Thompson, Alexander J.

Results: 82
    1

    6‐Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy.

    Published in:
    Internal Medicine Journal, 2024, v. 54, n. 11, p. 1856, doi. 10.1111/imj.16504
    By:
    • Yu, Natalie;
    • Lee, Tanya;
    • Tassone, Daniel;
    • Vogrin, Sara;
    • Phan, Steven;
    • Wu, Damien M.;
    • Zhang, Jason;
    • Wang, Luke;
    • Tjahyadi, Jason;
    • Dutt, Krishneel;
    • Liou, Hana;
    • Basnayake, Chamara;
    • Wright, Emily;
    • Niewiadomski, Ola;
    • Lust, Mark;
    • Schulberg, Julien;
    • Kamm, Michael A.;
    • Connell, William;
    • Thompson, Alexander J.;
    • Hilmi, Ida
    Publication type:
    Article
    2
    3

    Clinical outcomes amongst elderly patients with inflammatory bowel disease.

    Published in:
    Internal Medicine Journal, 2023, v. 53, n. 10, p. 1866, doi. 10.1111/imj.15928
    By:
    • Sivanathan, Vithoosharan;
    • Basnayake, Chamara;
    • Connell, William;
    • Wright, Emily;
    • Ding, John Nik;
    • Niewadomski, Ola;
    • Stanley, Annalise;
    • Wilson‐O'Brien, Amy;
    • Fry, Stephanie;
    • Samyue, Tamie;
    • Lust, Mark;
    • Flanagan, Emma;
    • Thompson, Alexander J. V.;
    • Kamm, Michael A.
    Publication type:
    Article
    4
    5
    6

    Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort.

    Published in:
    Digestive Diseases & Sciences, 2023, v. 68, n. 1, p. 291, doi. 10.1007/s10620-022-07483-y
    By:
    • Clark, Paul J.;
    • Valery, Patricia C.;
    • Strasser, Simone I.;
    • Weltman, Martin;
    • Thompson, Alexander J.;
    • Levy, Miriam;
    • Leggett, Barbara;
    • Zekry, Amany;
    • Rong, Julian;
    • Angus, Peter;
    • George, Jacob;
    • Bollipo, Steven;
    • McGarity, Bruce;
    • Sievert, William;
    • Macquillan, Gerry;
    • Tse, Edmund;
    • Nicoll, Amanda;
    • Wade, Amanda;
    • Chu, Geoff;
    • Harding, Damian
    Publication type:
    Article
    7

    Australian consensus recommendations for the management of hepatitis B.

    Published in:
    Medical Journal of Australia, 2022, v. 216, n. 9, p. 478, doi. 10.5694/mja2.51430
    By:
    • Lubel, John S;
    • Strasser, Simone I;
    • Thompson, Alexander J;
    • Cowie, Benjamin C;
    • MacLachlan, Jennifer;
    • Allard, Nicole L;
    • Holmes, Jacinta;
    • Kemp, William W;
    • Majumdar, Avik;
    • Iser, David;
    • Howell, Jess;
    • Matthews, Gail V
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15

    The impact of point‐of‐care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study.

    Published in:
    Journal of Viral Hepatitis, 2022, v. 29, n. 5, p. 375, doi. 10.1111/jvh.13664
    By:
    • Howell, Jessica;
    • Traeger, Michael W.;
    • Williams, Bridget;
    • Layton, Chloe;
    • Doyle, Joseph S.;
    • Latham, Ned;
    • Draper, Bridget;
    • Bramwell, Frances;
    • Membrey, Dean;
    • McPherson, Maggie;
    • Roney, Janine;
    • Stoové, Mark;
    • Thompson, Alexander J.;
    • Hellard, Margaret E.;
    • Pedrana, Alisa
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B.

    Published in:
    PLoS ONE, 2018, v. 13, n. 7, p. 1, doi. 10.1371/journal.pone.0199198
    By:
    • Wei, Lai;
    • Wedemeyer, Heiner;
    • Liaw, Yun-Fan;
    • Chan, Henry Lik-Yuen;
    • Piratvisuth, Teerha;
    • Marcellin, Patrick;
    • Jia, Jidong;
    • Tan, Deming;
    • Chow, Wan-Cheng;
    • Brunetto, Maurizia R.;
    • Diago, Moisés;
    • Gurel, Selim;
    • Morozov, Viacheslav;
    • He, Hua;
    • Zhu, Yonghong;
    • Wat, Cynthia;
    • Surujbally, Bernadette;
    • Thompson, Alexander J.
    Publication type:
    Article
    22
    23
    24
    25
    26
    27

    Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facility.

    Published in:
    Medical Journal of Australia, 2023, v. 218, n. 6, p. 256, doi. 10.5694/mja2.51885
    By:
    • MacIsaac, Michael B;
    • Whitton, Bradley;
    • Hubble, Adrian;
    • Cogger, Shelley;
    • Penn, Matthew;
    • Weeks, Anthony;
    • Elmore, Kasey;
    • Pemberton, David;
    • Anderson, Jenine;
    • Howard, Rebecca;
    • McKeever, Una;
    • Papaluca, Timothy;
    • Hellard, Margaret E;
    • Stoove, Mark;
    • Wilson, David;
    • Pedrana, Alisa;
    • Doyle, Joseph;
    • Clark, Nico;
    • Holmes, Jacinta;
    • Thompson, Alexander J
    Publication type:
    Article
    28
    29
    30
    31
    32

    Host genomics and HCV treatment response.

    Published in:
    Journal of Gastroenterology & Hepatology, 2012, v. 27, n. 2, p. 212, doi. 10.1111/j.1440-1746.2011.06918.x
    By:
    • Clark, Paul J;
    • Thompson, Alexander J
    Publication type:
    Article
    33

    Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.

    Published in:
    Journal of Gastroenterology & Hepatology, 2011, v. 26, n. 7, p. 1182, doi. 10.1111/j.1440-1746.2011.06722.x
    By:
    • Patel, Keyur;
    • Thompson, Alexander J;
    • Chuang, Wan-Long;
    • Lee, Chuan-Mo;
    • Peng, Chen-Yuan;
    • Shanmuganathan, Ganesananthan;
    • Thongsawat, Satawat;
    • Tanwandee, Tawesak;
    • Mahachai, Varocha;
    • Pramoolsinsap, Chutima;
    • Cho, Mong;
    • Han, Kwang Hyup;
    • Shah, Samir R;
    • Foster, Graham R;
    • Clark, Paul J;
    • Pulkstenis, Erik;
    • Subramanian, G. Mani;
    • McHutchison, John G
    Publication type:
    Article
    34
    35
    36
    37

    Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis.

    Published in:
    JAMA: Journal of the American Medical Association, 2015, v. 313, n. 17, p. 1736, doi. 10.1001/jama.2015.3868
    By:
    • Muir, Andrew J.;
    • Poordad, Fred;
    • Lalezari, Jacob;
    • Everson, Gregory;
    • Dore, Gregory J.;
    • Herring, Robert;
    • Sheikh, Aasim;
    • Kwo, Paul;
    • Hézode, Christophe;
    • Pockros, Paul J.;
    • Tran, Albert;
    • Yozviak, Joseph;
    • Reau, Nancy;
    • Ramji, Alnoor;
    • Stuart, Katherine;
    • Thompson, Alexander J.;
    • Vierling, John;
    • Freilich, Bradley;
    • Cooper, James;
    • Ghesquiere, Wayne
    Publication type:
    Article
    38
    39

    Non-invasive fibrosis algorithms are clinically useful for excluding cirrhosis in prisoners living with hepatitis C.

    Published in:
    PLoS ONE, 2020, v. 15, n. 11, p. 1, doi. 10.1371/journal.pone.0242101
    By:
    • Papaluca, Timothy;
    • Craigie, Anne;
    • McDonald, Lucy;
    • Edwards, Amy;
    • MacIsaac, Michael;
    • Holmes, Jacinta A.;
    • Jarman, Matthew;
    • Lee, Tanya;
    • Huang, Hannah;
    • Chan, Andrew;
    • Lai, Mark;
    • Sundararajan, Vijaya;
    • Doyle, Joseph S.;
    • Hellard, Margaret;
    • Stoove, Mark;
    • Howell, Jessica;
    • Desmond, Paul;
    • Iser, David;
    • Thompson, Alexander J.
    Publication type:
    Article
    40

    The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services.

    Published in:
    PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0235445
    By:
    • Traeger, Michael W.;
    • Pedrana, Alisa E.;
    • van Santen, Daniela K.;
    • Doyle, Joseph S.;
    • Howell, Jessica;
    • Thompson, Alexander J.;
    • El-Hayek, Carol;
    • Asselin, Jason;
    • Polkinghorne, Victoria;
    • Membrey, Dean;
    • Bramwell, Fran;
    • Carter, Allison;
    • Guy, Rebecca;
    • Stoové, Mark A.;
    • Hellard, Margaret E.
    Publication type:
    Article
    41
    42

    Treatment access is only the first step to hepatitis C elimination: experience of universal anti‐viral treatment access in Australia.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 9, p. 1223, doi. 10.1111/apt.15210
    By:
    • Doyle, Joseph S.;
    • Scott, Nick;
    • Sacks‐Davis, Rachel;
    • Pedrana, Alisa E.;
    • Thompson, Alexander J.;
    • Hellard, Margaret E.;
    • Hellard, Margaret;
    • Thompson, Alex;
    • Doyle, Joseph;
    • Dietze, Paul;
    • McBryde, Emma;
    • Sievert, William;
    • Stoove, Mark;
    • Higgs, Peter;
    • Petrie, Denis;
    • Vickerman, Peter
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50

    IL28 B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α.

    Published in:
    Journal of Gastroenterology & Hepatology, 2013, v. 28, n. 5, p. 861, doi. 10.1111/jgh.12110
    By:
    • Holmes, Jacinta A;
    • Nguyen, Tin;
    • Ratnam, Dilip;
    • Heerasing, Neel M;
    • Tehan, Jane V;
    • Bonanzinga, Sara;
    • Dev, Anouk;
    • Bell, Sally;
    • Pianko, Stephen;
    • Chen, Robert;
    • Visvanathan, Kumar;
    • Hammond, Rachel;
    • Iser, David;
    • Rusli, Ferry;
    • Sievert, William;
    • Desmond, Paul V;
    • Bowden, D Scott;
    • Thompson, Alexander J
    Publication type:
    Article